ICSC 1213 - POTASSIUM ARSENITE

« back to the search result list

POTASSIUM ARSENITE	ICSC: 1213 (April 2005)
Potassium metaarsenite Arsenious acid, potassium salt Potassium arsonate

CAS #: 10124-50-2

UN #: 1678

EC Number: 233-337-9

	ACUTE HAZARDS	PREVENTION	FIRE FIGHTING
FIRE & EXPLOSION	Not combustible. Gives off irritating or toxic fumes (or gases) in a fire.		In case of fire in the surroundings, use appropriate extinguishing media.

PREVENT DISPERSION OF DUST! AVOID ALL CONTACT! AVOID EXPOSURE OF (PREGNANT) WOMEN! IN ALL CASES CONSULT A DOCTOR!
	SYMPTOMS	PREVENTION	FIRST AID
Inhalation	Cough. Headache. Laboured breathing. Sore throat. See Ingestion.	Use closed system or ventilation.	Fresh air, rest. Refer for medical attention.
Skin	Redness. Pain.	Protective gloves. Protective clothing.	Remove contaminated clothes. Rinse and then wash skin with water and soap. Refer for medical attention .
Eyes	Redness. Pain.	Wear face shield or eye protection in combination with breathing protection if powder.	First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.
Ingestion	Abdominal pain. Burning sensation in the throat and chest. Vomiting. Diarrhoea. Dizziness. Headache. Shock or collapse.	Do not eat, drink, or smoke during work. Wash hands before eating.	Rinse mouth. Give a slurry of activated charcoal in water to drink. Induce vomiting (ONLY IN CONSCIOUS PERSONS!). Refer for medical attention .

SPILLAGE DISPOSAL	CLASSIFICATION & LABELLING
Personal protection: chemical protection suit including self-contained breathing apparatus. Do NOT let this chemical enter the environment. Sweep spilled substance into covered sealable, plastic containers. Vacuum spilled material with specialist equipment. Vacuum spilled material with specialist equipment. Carefully collect remainder. Then store and dispose of according to local regulations.	According to UN GHS Criteria Transportation UN Classification UN Hazard Class: 6.1; UN Pack Group: II
STORAGE
Separated from acids, strong oxidants, metals and food and feedstuffs. Dry. Well closed. Provision to contain effluent from fire extinguishing. Store in an area without drain or sewer access.
PACKAGING
Unbreakable packaging. Put breakable packaging into closed unbreakable container. Do not transport with food and feedstuffs. Marine pollutant.

POTASSIUM ARSENITE

ICSC: 1213

PHYSICAL & CHEMICAL INFORMATION
Physical State; Appearance WHITE HYGROSCOPIC POWDER. Physical dangers Chemical dangers Upon heating, toxic fumes are formed. Decomposes on heating. This produces toxic fumes. Reacts with acids. This produces toxic arsine gas (see ICSC 0222). Attacks many metals. This produces flammable/explosive gas (hydrogen - see ICSC 0001) and arsine.	Formula: see Notes Decomposes at 300°C Density: 8.76 g/cm³ Solubility in water: good

PHYSICAL & CHEMICAL INFORMATION

Physical State; Appearance
WHITE HYGROSCOPIC POWDER.

Physical dangers

Chemical dangers
Upon heating, toxic fumes are formed. Decomposes on heating. This produces toxic fumes. Reacts with acids. This produces toxic arsine gas (see ICSC 0222). Attacks many metals. This produces flammable/explosive gas (hydrogen - see ICSC 0001) and arsine.

Formula: see Notes

Decomposes at 300°C
Density: 8.76 g/cm³
Solubility in water: good

EXPOSURE & HEALTH EFFECTS
Routes of exposure The substance can be absorbed into the body by inhalation of its aerosol and by ingestion. Effects of short-term exposure The substance is irritating to the eyes, skin and respiratory tract. The substance may cause effects on the cardiovascular system, central nervous system, gastrointestinal tract and kidneys. This may result in severe gastroenteritis, loss of fluids and electrolytes, kidney impairment, cardiac disorders, collapse and shock. The effects may be delayed. Medical observation is indicated.	Inhalation risk A harmful concentration of airborne particles can be reached quickly when dispersed. Effects of long-term or repeated exposure Repeated or prolonged contact with skin may cause dermatitis and pigmentation disorders. The substance may have effects on the peripheral nervous system, bone marrow, kidneys, liver and mucous membranes. This may result in neuropathy, lesions of blood cells, kidney impairment, cirrhosis and perforation of the nasal septum. This substance is carcinogenic to humans. Animal tests show that this substance possibly causes toxicity to human reproduction or development.

EXPOSURE & HEALTH EFFECTS

Routes of exposure
The substance can be absorbed into the body by inhalation of its aerosol and by ingestion.

Effects of short-term exposure
The substance is irritating to the eyes, skin and respiratory tract. The substance may cause effects on the cardiovascular system, central nervous system, gastrointestinal tract and kidneys. This may result in severe gastroenteritis, loss of fluids and electrolytes, kidney impairment, cardiac disorders, collapse and shock. The effects may be delayed. Medical observation is indicated.

Inhalation risk
A harmful concentration of airborne particles can be reached quickly when dispersed.

Effects of long-term or repeated exposure
Repeated or prolonged contact with skin may cause dermatitis and pigmentation disorders. The substance may have effects on the peripheral nervous system, bone marrow, kidneys, liver and mucous membranes. This may result in neuropathy, lesions of blood cells, kidney impairment, cirrhosis and perforation of the nasal septum. This substance is carcinogenic to humans. Animal tests show that this substance possibly causes toxicity to human reproduction or development.

OCCUPATIONAL EXPOSURE LIMITS
EU-OEL: (inhalable fraction): 0.01 mg/m³ as TWA; (see Notes)

ENVIRONMENT
The substance is toxic to aquatic organisms.

NOTES
The compound has variable composition; the commercial grade formula corresponds approximately to KAsO_2·HAsO_2. Depending on the degree of exposure, periodic medical examination is suggested. Do NOT take working clothes home. For the copper smelting sector, the EU OEL value shall apply from 11 July 2023.

ADDITIONAL INFORMATION

EC Classification
Symbol: T, N; R: 23/25-50/53; S: (1/2)-20/21-28-45-60-61; Note: A, 1

All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material.